Critezma-1.25 Respules

Description

Ipratropium Bromide 500 mcg + Levosalbutamol 1.25 mg Respules for bronchospasm and obstructive airway conditions. Quality respiratory respules available for pharma franchise & PCD business.

Product Description

Ipratropium Bromide 500 mcg + Levosalbutamol 1.25 mg Respules is a dual bronchodilator formulation intended for nebulization in patients with bronchospasm and obstructive airway conditions, as prescribed by a healthcare professional.

The combination works through two complementary bronchodilating mechanisms:

• Ipratropium Bromide 500 mcg is an anticholinergic bronchodilator that helps relax airway muscles and improve airflow.
• Levosalbutamol 1.25 mg is a selective β2-adrenergic agonist that relaxes bronchial smooth muscle and helps open the airways.

The unit-dose respule format provides convenient administration through a nebulizer, making it a valuable product for respiratory, pediatric, pulmonology, and general medicine pharma franchise portfolios.

Key Benefits

✔ Dual bronchodilator action
✔ Helps relieve bronchospasm and breathing difficulty
✔ Helps improve airflow through the airways
✔ Convenient unit-dose respule presentation
✔ Suitable for nebulization as prescribed
✔ Valuable respiratory-care product for hospitals and clinics
✔ High-demand respiratory product for pharma franchise

Composition

Each respule contains:

• Ipratropium Bromide – 500 mcg
• Levosalbutamol – 1.25 mg

(Please verify the exact salt, concentration, fill volume, and approved formulation before publishing.)

Indications / Uses

• Bronchospasm
• Obstructive airway conditions
• Asthma-associated bronchospasm
• Chronic obstructive pulmonary disease (COPD)
• Wheezing associated with reversible airway obstruction

Use should be based on the physician’s diagnosis and prescription.

Dosage Form

• Respules / Nebulizer Solution

Administration: For inhalation through a suitable nebulizer only. Use as directed by the physician. Do not swallow or inject.

Packaging

• 2.5 ml / 3 ml Unit-Dose Respules
• 5 or 10 respules per strip
• 20 / 30 respules per box
• Sterile, unit-dose packaging
• Premium respiratory-care packaging
• Custom private-label packaging available

Pharma Franchise Opportunity

We offer Ipratropium Bromide + Levosalbutamol Respules Pharma Franchise with:

✅ Monopoly pharma franchise rights
✅ Quality-assured respiratory formulation
✅ High-demand nebulization product
✅ Attractive packaging and branding support
✅ Competitive pricing with attractive margins
✅ Reliable product availability

This formulation is an excellent addition to respiratory, pulmonology, pediatric, hospital, and general medicine pharma franchise portfolios, providing strong potential for prescription and institutional demand.

Why Choose Our Respiratory Respules?

• Dual-action bronchodilator formulation
• Convenient unit-dose presentation
• Suitable for nebulizer-based respiratory therapy
• Quality-focused sterile manufacturing
• Attractive packaging and branding options
• Strong market potential in respiratory care